Heron Therapeutics Inc (NASDAQ:HRTX)

12.47
Delayed Data
As of May 22
 -0.22 / -1.73%
Today’s Change
6.51
Today|||52-Week Range
16.49
+23.96%
Year-to-Date

Today’s Trading

Previous close12.69
Today’s open12.68
Day’s range12.45 - 13.02
Volume310,072
Average volume (3 months)275,640
Market cap$376.0M
Dividend yield--
Data as of 4:00pm ET, 05/22/2015

Growth & Valuation

Earnings growth (last year)+16.08%
Earnings growth (this year)-0.28%
Earnings growth (next 5 years)+65.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book5.88

Competitors

 Today’s
change
Today’s
% change
DERMDermira Inc-0.16-1.07%
PGNXProgenics Pharmaceut...-0.04-0.72%
NHTCNatural Health Trend...-0.45-1.47%
XNPTXenoport Inc-0.06-0.96%
Data as of 4:00pm ET, 05/22/2015

Financials

Next reporting dateAugust 10, 2015
EPS forecast (this quarter)-$0.71
Annual revenue (last year)$0.00
Annual profit (last year)-$76.4M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Barry D. Quart
President, Director &
Chief Commercial Officer
Robert H. Rosen
Corporate headquarters
Redwood City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers